文献速递主动脉疾病

近肾腹主动脉瘤开放与腔内修复的中期结果比较

Comparison between Open and Endovascular Repair for the Treatment of Juxtarenal Abdominal Aortic Aneurysms: A Single-Center Experience with Midterm Results.
PubMed 文献 · Ann Vasc Surg · 2017-02-24

单中心回顾性分析152例近肾腹主动脉瘤,比较开放手术(OSR,81例)与腔内修复(EVAR,71例)的中期结局。EVAR组年龄更大、合并症更多,围术期指标更优但再干预率更高;两组30天死亡率与远期生存无显著差异。OSR仍为低危患者首选,EVAR可作为高危患者替代选择。

要点

  • EVAR组再干预率显著高于OSR组(P=0.01),但两组30天死亡率与远期生存无差异。
  • OSR组手术时间、住院时间和围术期失血量均显著高于EVAR组(P均<0.001)。
  • OSR术后透析与手术时间和出血量相关,EVAR术后死亡与术后肌酐超过3.0 mg/dL相关。

核心结论

  • OSR与EVAR治疗近肾腹主动脉瘤均可获得可接受的中期结局,但EVAR再干预更频繁。
  • OSR似乎是低危患者最合适的一线治疗,EVAR可作为高危患者的替代选择。

研究设计与样本

  • 单中心回顾性研究,纳入152例近肾腹主动脉瘤,排除主动脉夹层和破裂病例。
  • OSR组81例,EVAR组71例(使用多种开窗和烟囱EVAR技术)。
  • 采用Cox模型评估生存,并分析术后透析率。

主要发现

  • EVAR组平均年龄显著更高(总体74.5岁;OSR 71岁;EVAR 77岁)。
  • EVAR组术前高血清肌酐、脑血管病和慢性阻塞性肺疾病更常见。
  • OSR组平均手术时间、住院时间和围术期失血量均显著更高(P均<0.001)。
  • 总体30天死亡率为1.9%,两组无统计学差异。
  • EVAR组再干预率显著更高(P=0.01);1、3、5、7年总生存率分别为97.4%、91.6%、86.3%、82.9%,两组无显著差异。

关键数值与推荐

  • EVAR术后死亡与术后肌酐超过3.0 mg/dL相关。
  • OSR术后透析与手术时间和出血量相关。

临床怎么用

  • 低危近肾腹主动脉瘤患者可优先考虑OSR,以降低再干预风险。
  • 高危患者可选择EVAR,但需告知再干预率较高并加强术后随访。

局限性

  • 单中心回顾性设计,样本量有限,选择偏倚可能存在。
  • EVAR组年龄和合并症负担更重,组间基线不可比。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate the optimal treatment for juxtarenal abdominal aortic aneurysm (JAAA), we compared the outcomes of open surgical repair (OSR) with endovascular aortic repair (EVAR) using a variety of fenestrated and snorkel EVARs. METHODS: We evaluated overall survival, aneurysm-related death, reintervention, and renal impairment in 152 JAAAs retrospectively, excluding cases of aortic dissection and rupture. Cox models were used to assess survival and assessed postoperative dialysis rates following surgery. RESULTS: OSR and EVAR were performed in 81 and 71 patients, respectively. The mean age was significantly higher in the EVAR group (overall, 74.5 years; OSR, 71 years; and EVAR; 77 years). High preoperative serum creatinine levels, cerebrovascular disease, and chronic obstructive pulmonary disease were more prevalent in the EVAR group. Mean operative time, hospital stay, and perioperative blood loss were significantly greater in the OSR group (P < 0.001 for all). The overall 30-day mortality was 1.9% with no statistical difference between 2 groups. The reintervention rate was significantly higher in the EVAR group (P = 0.01). Overall survival rates at 1, 3, 5, and 7 years were 97.4%, 91.6%, 86.3%, and 82.9%, respectively, with no significant difference between groups. Mortality in EVAR was associated with over 3.0 mg/dL of postoperative creatinine, and postoperative dialysis following OSR was associated with operative time and volume of bleeding. CONCLUSIONS: Acceptable outcomes were observed with OSR and EVAR. However, reintervention was more frequently required following EVAR. OSR appears to be the most appropriate first-line treatment for JAAA in good-risk patients; however, EVAR may represent an alternative option in high-risk patients.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Maeda K, Ohki T, Kanaoka Y, et al. Comparison between Open and Endovascular Repair for the Treatment of Juxtarenal Abdominal Aortic Aneurysms: A Single-Center Experience with Midterm Results. Ann Vasc Surg. 2017. PMID: 28238929. doi:10.1016/j.avsg.2016.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。